Use of GSK-3 inhibitors for the treatment of prostate cancer

Details for Australian Patent Application No. 2005273710 (hide)

Owner Imperial Innovations Limited

Inventors Kypta, Robert Martin

Agent Griffith Hack

Pub. Number AU-A-2005273710

PCT Pub. Number WO2006/018633

Priority 0418328.1 17.08.04 GB

Filing date 17 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/404 (2006.01)

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018633 Priority application(s): WO2006/018633

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005273715-Information selection

2005273705-Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer